In this study, we explored the potential molecular mechanisms underlying the biological behavioural changes of hepatoma cells after KIF18A dysregulation to find new diagnostic targets or potential therapeutic targets for HCC. This evidence concerns the gene KIF18A and hepatocellular carcinoma.